Luis Augusto Tavares Russo

Author

Also Known As

L. A. Russo, L. Russo, L.A. Russo, LUIS AUGUSTO RUSSO, Luis A Russo, Luis A. Russo, Luis A.T. Russo, Luis Augusto Russo, Luis Augusto T. Russo, Luis Augusto Tavares Russo

Publications

2.5K

Citations

H-Index

Concepts

All Affiliations

Medical University of Graz Centro Paulista de Investigação Clinica Eli Lilly (United States)Centre Hospitalier Universitaire Brugmann Maastricht University

About

Luis Augusto Tavares Russo is an author at Medical University of Graz specializing in medicine, osteoporosis, and women's health.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	6	6	960
2	Health Sciences	2	2	113
3	Clinical Nutrition	2	2	124
4	Diabetes	1	1	40
5	Nutrition	1	1	73

Luis Augusto Tavares Russo

Publications

2.3K

Citations

H-Index

Page 1

	Year	Citations
Effect of Abaloparatide vs Placebo on New Vertebral Fractures in Postmenopausal Women With Osteoporosis Paul D. Miller, Gary Hattersley, Bente Juel Riis, JAMA	2016	824
Effects of teriparatide and risedronate on new fractures in post-menopausal women with severe osteoporosis (VERO): a multicentre, double-blind, double-dummy, randomised controlled trial David L. Kendler, Fernando Marín, Cristiano A. F. Zerbini, The Lancet Bone DiseaseBone HealthNew FracturesPost-menopausal WomenSevere Osteoporosis	2017	554
Fracture Risk and Zoledronic Acid Therapy in Men with Osteoporosis Steven Boonen, Jean‐Yves Reginster, Jean‐Marc Kaufman, New England Journal of Medicine	2012	347
The effect of teriparatide compared with risedronate on reduction of back pain in postmenopausal women with osteoporotic vertebral fractures Peyman Hadji, José Zanchetta, Luis Augusto Tavares Russo, Osteoporosis International Pain MedicineGeriatric Fracture CareSurgeryPain ManagementOsteoporosis	2011	133
Effects of Teriparatide Compared with Risedronate on the Risk of Fractures in Subgroups of Postmenopausal Women with Severe Osteoporosis: The VERO Trial Piet Geusens, Fernando Marín, David L. Kendler, Journal of Bone and Mineral Research Fracture DiagnosticsSevere OsteoporosisOsteoporosisOrthopaedic SurgeryMost Subgroups	2018	109
A randomized, double-blind, multicenter, placebo-controlled study to evaluate the efficacy and safety of oral salmon calcitonin in the treatment of osteoporosis in postmenopausal women taking calcium and vitamin D Kim Henriksen, I. Byrjalsen, J.R. Andersen, Bone Bone DiseaseNutritionBone HealthClinical NutritionOral Salmon Calcitonin	2016	73
Bone mineral density response rates are greater in patients treated with abaloparatide compared with those treated with placebo or teriparatide: Results from the ACTIVE phase 3 trial Paul D. Miller, Gary Hattersley, Esther Yuet Ying Lau, Bone	2018	62
Correlation between 25-hydroxyvitamin D levels and latitude in Brazilian postmenopausal women: from the Arzoxifene Generations Trial Henrique Pierotti Arantes, Carolina A. M. Kulak, César Eduardo Fernandes, Osteoporosis International MedicineClinical NutritionGynecologyMenopausePostreproductive Health	2013	51
Increased epicardial adipose tissue in type 1 diabetes is associated with central obesity and metabolic syndrome Denise Momesso, Isabela Bussade, Marcio Antonio Epifanio, Diabetes Research and Clinical Practice ObesityMetabolic SyndromeType 1Body CompositionMetabolic Disorder	2010	40
Association of back pain with hypovitaminosis D in postmenopausal women with low bone mass Ariane Viana de Souza e Silva, Paulo Gustavo Sampaio Lacativa, Luis Augusto Tavares Russo, BMC Musculoskeletal Disorders	2013	30

Page 1